Abstract:Abstract Abstract 1926 Gene regulatory networks with regulatory circuits at different domains are the fundamental mechanism in phenotypic expression of the underlying genome. Regulation by transcription factors (TF) and microRNA (miRNA) are important such domains beside other epigenetic and post-translational gene regulation. With many genomic data sets in recent years, improved understanding of such regulatory network motifs would be of substantial value to find causal genomic alternations in the cancer. A particular example of one such TF-miRNA-gene feed-forward loop (FFL) is, TF (e.g. MYC) regulates the transcription of one or a set of genes/TFs (e.g. E2F1), and the TF (MYC) also regulates the transcription of one or a set of miRNAs (e.g. mir-17-5p and mir-20a), which in turn regulate the same gene or set of genes (E2F1). We hypothesize that an integrative analysis of network motifs and gene expression data can discover experimentally testable TF-miRNA regulation relationships. We have developed computational algorithms based on network motifs and expression data for identifying TF-miRNA pairs important in biological processes and disease states. We construct candidate regulatory networks and rank them using network structure and expression data. We based our prediction on a score-based algorithm, and analyzed publicly available paired gene expression-miRNA profile data from 60 multiple myeloma (MM) patients and 5 samples from healthy donors. We have identified 65 FFLs containing TF-miRNA-gene networks with loss of negative feedback regulation in MM, which supports the uncontrolled growth, anti-apoptosis or other oncogenic effects in MM. Two of the prominent examples involve known proto-oncogenes, c-Myc and FOXA2. We also observed FFL involving c-Myc - mir-629 and target gene PRDM16. Here, concurrently up-regulated c-Myc (TF) and down-regulated mir-629 favors overexpression of target gene, PRDM16, with reported role in myelodysplastic syndrome and acute myeloid leukemia. Similarly, we observe FFL involving HOXA2 – mir-15a and mir-214 and target genes RUNX1T1, HOXC13, NKD1 and PRDM16. Using independent gene expression and miRNA public datasets, we have validated the loss of the negative regulation of these FFLs in MM. We are in the process of functionally validating these identified loops and the associated changes. We will present the predicted FFLs and their biological and functional significance in MM. Such integrative analysis of network motifs and gene expression data can discover experimentally testable TF-miRNA-gene regulatory network and will be instrumental in understanding the biology of the disease, developing clinically relevant integrated models, and translating basic research into targeted therapy. Disclosures: Anderson: Millennium Pharmaceuticals: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau. Munshi:Millennium Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees; Onyx: Membership on an entity's Board of Directors or advisory committees.

Emerging Roles of I-Motif in Gene Expression and Disease Treatment

The i-Motif as a Molecular Target: More Than a Complementary DNA Secondary Structure

The Formation and Characteristics of the I-Motif Structure Within the Promoter of the C-Myb Proto-Oncogene.

i-Motif DNA: structural features and significance to cell biology

Structural Stability and Ph-Dependent Conformational Dynamics of Noncanonical I-Motif DNA

I-motif DNA structures are formed in the nuclei of human cells

Quadruplexes Are Everywhere…On the Other Strand Too: the I-Motif

Mechanistic insights into poly(C)-binding protein hnRNP K resolving i-motif DNA secondary structures

Insights into the Molecular Structure, Stability, and Biological Significance of Non-Canonical DNA Forms, with a Focus on G-Quadruplexes and i-Motifs

Human genomic DNA is widely interspersed with i-motif structures

Structural properties and influence of solvent on the stability of telomeric four-stranded i-motif DNA.

Theranostic approach to specifically targeting the interloop region of BCL2 i-motif DNA by crystal violet

Nanopore-Based Single-Molecule Investigation of Cation Effect on the i-Motif Structure

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Prediction of DNA i-motifs via machine learning

An Integrative Analysis of Network Motifs and Gene Expression Data to Discover Experimentally Testable Transcription Factor-Mirna-Gene Regulatory Loops in Multiple Myeloma

In-cell NMR suggests that DNA i-motif levels are strongly depleted in living human cells

Secondary DNA structures as molecular targets for cancer therapeutics

Polymorphic and Higher-Order G-Quadruplexes as Possible Transcription Regulators: Novel Perspectives for Future Anticancer Therapeutic Applications

Multiple factors regulate i-motif and G-quadruplex structures in vitro: analysis of repeated and non-repeated polyG/polyC clusters by circular dichroism

The emerging role of ISWI chromatin remodeling complexes in cancer